Clinical significance of chemoradiotherapy and surgical resection for cT4 esophageal cancer

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3275-3282

  Morita, Masaru ^a,b   Toh, Yasushi ^a   Saeki, Hiroshi ^b   Sugiyama, Masahiko ^a   Ohgaki, Kippei ^a   Maehara, Shin Ichiro ^a   Minami, Kazuhito ^a   Ikeda, Yasuharu ^a   Sakaguchi, Yoshihisa ^a   Okamura, Takeshi ^a   Uehara, Satoru ^a   Maehara, Yoshihiko ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Esophageal cancer; Esophagectomy; T4

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ALLERGY; ANEMIA; ANOREXIA; ARTICLE; CANCER MORTALITY; CANCER STAGING; CHEMORADIOTHERAPY; CT4 ESOPHAGEAL CANCER; ESOPHAGOBRONCHIAL FISTULA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FATIGUE; FEMALE; GRANULOCYTOPENIA; HEMOPTYSIS; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; OVERALL SURVIVAL; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RESPIRATORY FAILURE; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84865681926     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. SetoY, Chin K, Gomi K, Kozuka T, Fukuda T, Yamada K, Matsubara T, Tokunaga M, Kato Y, Yafune A and Yamaguchi T: Treatment of thoracic esophageal carcinoma invading adjacent structures. Cancer Sci 98: 937-942, 2007.
2. Morita M, Yoshida R, Ikeda K, Egashira A, Oki E, Sadanaga N, Kakeji Y, Yamanaka T and Maehara Y: Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute. Surgery 143: 499-508, 2008.
3. Morita M, Masuda T, Okada S, Yoshinaga K, Saeki H, Tokunaga E, Endo K, Emi Y, Kakeji Y and Maehara Y: Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications. Anticancer Res 29: 2555-2562, 2009.
4. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr., Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, Asbell SO, Graham MV and Leichman LL: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281: 1623-1627, 1999.
5. Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Seki S, Kaneko K and Nakamura A: Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17: 2915-2921, 1999.
6. Kaneko K, Ito H, Konishi K, Kurahashi T, Ito T, Katagiri A, Yamamoto T, Kitahara T, Mizutani Y, Ohtsu A and Mitamura K: Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus. Br J Cancer 88: 18-24, 2003.
7. Crosby TD, Brewster AE, Borley A, Perschky L, Kehagioglou P, Court J and Maughan TS: Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br J Cancer 90: 70-75, 2004.
8. Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y and Shigeoka H: Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 53: 134-139, 2002.
9. Ishida K, Ando N, Yamamoto S, Ide H and Shinoda M: Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol 34: 615-619, 2004.
10. Van Raemdonck D, Van Cutsem E, Menten J, Ectors N, Coosemans W, De Leyn P and Lerut T. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration. Eur J Cardiothorac Surg 11: 828-837, 1997.
11. Yano M, Tsujinaka T, Shiozaki H, Inoue M, Doki Y, Yamamoto M, Tanaka E, Inoue T and Monden M: Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus. J Surg Oncol 70: 25-32, 1999.
12. Ikeda K, Ishida K, Sato N, Koeda K, Aoki K, Kimura Y, Iwaya T, Ogasawara S, Iijima S, Nakamura R, Uesugi N, Maesawa C and Saito K: Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. Dis Esophagus 14: 197-201, 2001.
13. Noguchi T, Moriyama H, Wada S, Takeno S, Wakisaka M, Mori H and Uchida Y: Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma. Dis Esophagus 16: 94-98, 2003.
14. Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Matono S, Mori N, Shirouzu K, Yamana H, Suzuki G, Hayabuchi N and Matsui M: Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg 29: 25-30; discussion 30-21, 2005.
15. de Manzoni G, Pedrazzani C, Pasini F, Bernini M, Minicozzi AM., Giacopuzzi S, Grandinetti A and Cordiano C: Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. J Surg Oncol 95: 261-266, 2007.
16. Miyoshi N, Yano M, Takachi K, Kishi K, Noura S, Eguchi H, Yamada T, Miyashiro I, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Doki Y and Imaoka S: Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer. J Surg Oncol 99: 302-306, 2009.
17. Morita M, Nakanoko T, Fujinaka Y, Kubo N, Yamashita N, Yoshinaga K, Saeki H, Emi Y, Kakeji Y, Shirabe K and Maehara Y: In-hospital mortality after a surgical resection for esophageal cancer: Analyses of the associated factors and historical changes. Ann Surg Oncol 18: 1757-1765, 2011.
18. Japan Esophageal Society (ed.). Japanese Classification of Esophageal Cancer. Tokyo: Kanehara Co.Ltd., 2008.
19. Swisher SG, Wynn P, Putnam JB, Mosheim MB, Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA and Walsh GL: Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123: 175-183, 2002.
20. Tachimori Y, Kanamori N, Uemura N, Hokamura N, Igaki H and Kato H: Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137: 49-54, 2009.
21. Morita M, Kumashiro R, Hisamatsu Y, Nakanishi R, Egashira A, Saeki H, Oki E, Ohga T, Kakeji Y, Tsujitani S, Yamanaka T and Maehara Y: Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy. J Gastroenterol 46: 1284-1291, 2011.
22. Yamabe Y, Kuroki Y, Ishikawa T, Miyakawa K, Kuroki S and Sekiguchi R: Tumor staging of advanced esophageal cancer: combination of double-contrast esophagography and contrast-enhanced CT. Am J Roentgenol 191: 753-757, 2008.
23. Toh Y, Ohga T, Itoh S, Kabashima A, Yamamoto K, Adachi E, Sakaguchi Y, Okamura T and Hirata H: Treatment results of radical surgery and definitive chemoradiotherapy for patients with submucosal esophageal squamous cell cancinomas. Anticancer Res 26: 2487-2491, 2006.
24. National Cancer Institute. Common Terminology Criteria for Adverse Events v.4.0 (CTCAE). http://ctep.cancer.gov/protocolDevelopment/electronic- applications/ctc.htm.
25. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC and Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
26. Eisterer W, de Vries A, Kendler D, Spechtenhauser B, Konigsrainer A, Nehoda H, Virgolini I, Lukas P, Bechter O, Woll E and Ofner D: Triple induction chemotherapy and chemoradiotherapy for locally advanced esophageal cancer. A phase II study. Anticancer Res 31: 4407-4412, 2011.
27. Matsubara T, Ueda M, Kokudo N, Takahashi T, Muto T and Yanagisawa A: Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion. World J Surg 25: 279-284, 2001.
28. Shimada H, Shiratori T, Okazumi S, Matsubara H, Nabeya Y, Shuto K, Akutsu Y, Hayashi H, Isono K and Ochiai T: Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience. J Am Coll Surg 206: 48-56, 2008.